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Abstract 
This paper investigates changes in public health care use in 28 transition countries in the aftermath 
of the global financial crisis using data on more than 60 thousand households from “Life in 
Transition” surveys II and III conducted by the European Bank for Reconstruction and 
Development in 2010 and 2016. A difference-in-difference model with robust standard errors 
clustered at a country level is applied to two sets of transition countries defined by their 
membership status in the European Union. While there was no difference in public health care 
use between the two groups in 2010 the share of households using the public health care system 
dropped by a remarkable 22.2% points between 2010 and 2016 in non-EU transition countries 
compared to new EU members. There is also some evidence of crowding out of public health care 
with private out-of-pocket expenditures in non-EU members. These findings represent a serious 
policy concern in terms of falling access to health care in non-EU transition countries. If one 
believes in equity benefits from access to public health care for all compared to private out-of-
pocket expenditures these results also demonstrates a clear benefit of EU membership. 
 
Introduction 
Mixed public-private financing of health and education have been in the focus of economists’ 
attention for a long time (Stiglitz 1974, Pardo and Schott 2012). Although public provision of 
health care predominates in most countries private health care often complements or substitutes 
for public finance (Buckley et al., 2016). The discussion of mixed financing of health in the literature 
centers on efficiency versus equity in access to care. On the one hand, access to private providers 
can reduce long waiting lines in public health care system and improve the overall efficiency of the 
health care system (Cullis and Jones 1985, Hoel and Sæther 2003, Marchand and Schroyen 2005). 
On the other hand, such a mixed system can lead to cream-skimming (Barros and Olivella 2005, 
González 2005) when substitutable private services ‘crowds out’ public provision resulting in a 
lower overall health care provision (Brekke and Sørgard 2007). 
Transition countries in this respect represent an interesting special case given that most of them 
initially adopted centrally-planned “Semashko” system with minor to no private sector 
involvement (Rechel and McKee 2009, Wagstaff and Moreno-Serra 2009). After the collapse of 
the Eastern Bloc in the beginning of the 1990s, transition countries started to implement elements 
of private health care (Waters et al. 2008).  
From a theoretical point of view such a mixed provision is less costly than systems with a purely 
public monopoly and it also results in a welfare improvement compared to the strictly private 
regime (Jofre-Bonet 2000). At the same time, compared to a purely public system a mixed system 
of health care finance may result in higher health care prices with sicker and poorer people being 
left untreated (Buckley et al. 2012). Hence, it is important to study the evolution of transition 
countries from a purely public health financing model toward a mixed system. 
Another important consideration is the initially high rate of public health care utilisation that 
characterises countries of the former Eastern Bloc (Chubrik et al., 2011). For example, in 2010 
according to the “Life in Transition II” survey 70% of the population in transition counties used 
public health care in the previous 12 months (Steves et al. 2011). By 2016 this rate dropped to 56% 
of the population in the 12 months prior to the “Life in Transition III” survey (European Bank 
for Reconstruction and Development 2016) which is much closer to the developed European 
countries (equal to 55% in Germany and 62% in Italy).  
A number of policy related questions arises in respect to this major decline. What were the reasons 
for such a drastic decline in public health system use? Was this decline the same in all transition 
countries or did some large differences exist? Finally, what are the possible welfare implications of 
this reduction for equity in access to care? 
To address these questions, this paper explores trends in public versus private health care use in 
the aftermath of the global financial crisis using data on more than 60 thousand households from 
the “Life in Transition” surveys II and III conducted in 28 transition nations in 2010 and 2016. 
For the purposes of this study, transition countries are divided into two relatively homogeneous 
groups in terms of economic development and implemented reforms. Specifically, transition 
countries are differentiated on the basis of their EU membership status by arguing that more 
developed and reform-oriented countries became new EU members.1  
The hypothesis to be tested is whether there is any change in population reliance on public health 
care in these two distinct groups of transition countries. The answer to this question is important 
for understanding the role of the government in coping with the consequences of the global 
financial crisis in terms of population access to care. 
Descriptive statistics reveal a higher level of economic development as well as better public 
financing of health care in new EU member states. The results of the difference-in-difference 
estimation do not indicate any gap in public health care use between non-EU and new EU 
transition countries in 2010. However, the share of households using the public health care system 
dropped by a remarkable 22.1% points between 2010 and 2016 in non-EU transition countries 
compared to new EU members. There is also some evidence of crowding out of public health care 
with private out-of-pocket expenditures in non-EU members. These findings represent a serious 
policy concern in terms of falling access to health care in non-EU transition countries.  
To the best of the author’s knowledge this is the first paper that identifies such a substantial 
divergence in public health care use in two groups of transition countries. The reported results 
should be trustworthy because they are based on large nationally representative samples for all 
transition countries. In addition, using of robust standard errors clustered at country level provides 
the most reliable estimates which also survive multiple robustness checks in four different model 
specifications and three different sample definitions.  
This paper is organised as follows. Firstly, the “Data and methods” section describes the “Life in 
Transition” survey and its methodology, defines outcome variables as well as included covariates 
                                                          
1 Alternatively, one could divide transition countries on the basis of whether they adopted social health insurance 
(SHI) system or not. However, this differentiation does not seem indicative of health reforms because 22 out of 28 
countries in the region have introduced systems of social health insurance (Rechel and McKee 2009).  
 
and describes the estimation approach. Secondly, the “Results” section provides descriptive 
statistics, estimation results and robustness checks. Finally, the policy and welfare implications are 
discussed in the last section. 
 
Data and Methods 
The Life in Transition survey 
This paper employs repeated cross-sectional data from the “Life in Transition” surveys II and III 
(LiTS II and LiTS III) conducted in 28 transition countries by the European Bank for 
Reconstruction and Development (EBRD) in 2010 and 2016.2 “Life in Transition” is a nationally 
representative survey including all countries from a former Eastern Bloc and some other European 
countries for comparison. The LiTS III survey instrument was largely based on the LiTS II 
questionnaire consisting of nine modules with questions about the demographic and economic 
characteristics of the household, utilities and consumption patterns, work history and employment, 
values and attitudes, governance and use of public services (EBRD 2016). The survey was 
conducted by means of a multi-stage random probability clustered sampling stratified by 
geographical region and level of urbanity. Respondents are drawn randomly using a two-stage 
sampling method, with census enumeration areas as Primary Sampling Units and households as 
secondary sampling units (Grosjean 2014).3 The “Life in Transition” survey data have been actively 
used in published research dealing with transition countries (Guriev and Zhuravskaya 2009; 
Cojocaru 2014; Djankov, Nikolova and Zilinsky 2016). 
 
 
 
                                                          
2 Although “Life in Transition” survey I is also available for 2006 the formulation of the question was different: 
“During the past 12 months have you personally used these services?”. Since 2010 and 2016 surveys asked about any 
household members (and not just the respondent) this paper does not include the 2006 data.  
3 LiTS III used 75 Primary Sampling Units (PSUs) including 50 PSUs from LiTS II and 25 new PSUs in an attempt 
to rebalance the old sample based on the updated population information (EBRD 2016). 
Outcome variables 
Three indicator variables are constructed to capture various forms of health care use by more than 
60 thousand households in the final sample. The first variable, “Used any health care” takes a value 
of 1 if a household spent more than zero on the “Health (including medicines and health 
insurance)” category or any household member used public health care in the last 12 months.4 This 
is the most broad category capturing public, private and mixed use of health care systems. This 
variable is further divided into separate disjoint indicators for public (or mixed) and private health 
care use. 
The dummy variable “Used public health care” takes a value of 1 if any household member used 
public health care in the previous year and 0 otherwise.5 Finally, it is also possible to identify 
households who did not use public health care but had positive out-of-pocket expenditures on 
private health care and medicines. Specifically, the variable “Used private health care only” takes a 
value of 1 if a household reported positive health care expenditures but did not use public health 
care in the previous 12 months and zero otherwise. 93.0% of households used any health care, 
while 62.3% applied for public (and mixed) health care and 28.5% for private health care only in 
2016. 
 
Estimation approach 
In order to quantify the crowding out of public health care in non-EU transition countries this 
paper uses a linear probability model with robust standard errors clustered at the country level. 
Specifically, let “HH used HCit” be a dummy variable taking a value of 1 for household i that used 
health care in the period t, modeled as difference-in-difference  
                                                          
4 The exact question formulation is: “And approximately how much did your household spend on each of these 
items during the past 12 months?” 
5 The exact question formulation is: “During the past 12 months have you or any member of your household used 
these services? Receive medical treatment in the public health system”. This variable identifies those households which 
definitely used public health care but in addition could have out-of-pocket expenditures on private health care. Only 
2.1% of households used public health care with zero out-of-pocket expenditures. 
HH used HCit = α + βXit + δD2016 + εDNon-EU + ζD2016*DNon-EU + ηit .               (1) 
Equation (1) represents a basic model including only exogenous socio-demographic characteristics 
of a household in a vector Xit from the “Life in Transition” survey: household size and age of the 
primary respondent, including squared terms to capture non-linearity; number of children under 
18 and older adults over 60 years old in the household; indicator variables for respondent with 
post-secondary education and higher education; an indicator variable for urban households.  
In addition, this paper estimates a full model  
HH used HCit = θ + λZit + μWt + νD2016 + ξDNon-EU + πD2016*DNon-EU + ρit ,   (2) 
where Zit  includes all variables in Xit and a set of socio-economic variables and Wt  includes 
economy-wide characteristics from World Development Indicators by the World Bank which are 
lagged 2 years due to data not yet being available for 2015 and 2016. Socio-economic variables are 
indicator variables for households living in a detached house or apartment; households with a car, 
households owning a computer at home and having internet access.  
Macroeconomic variables from World Development Indicators include Gross Domestic Product 
(GDP) per capita in constant Purchasing Power Parity (PPP) 100 dollars; PPP exchange rate 
devaluation over the last 4 years; unemployment in % from International Labour Organization 
(ILO); urban population in %; DPT immunization among 12-23 month old children; health 
expenditure (HE) per capita in constant $100 PPP; out-of-pocket health expenditure as a 
percentage of the total HE; public health expenditure as a percentage in the total HE; public HE 
as a percentage of government expenditure.  
The global financial crisis could have affected health care utilisation indirectly through changes in 
household economic characteristics, making them potentially endogenous. To ensure that results 
are robust to this potential endogeneity problem this paper reports coefficients from a basic model 
(including only exogenous demographic variables) and estimates from a full model.6  
                                                          
6 This comparison is also helpful to ensure that potential multicollinearity (i.e., owning a computer and having 
internet access at home) is not driving results either. 
Both models also include a set of dummy variables capturing potentially diverging trends in health 
care use by EU and non-EU countries. Specifically, D2016 is an indicator variable taking a value of 
1 if the observation year is 2016 and 0 if it is 2010. DNon-EU is a dummy variable equal to 1 for 
transition countries which are not members of the European Union and 0 for EU transition 
countries.7 In this formulation, the key coefficient of interest is on a cross-term D2016*DNon-EU 
showing how health care use in non-EU transition countries in 2016 was different from other 
region-year combinations (Coupe and Obrizan 2016). 
 
Results 
Descriptive statistics 
This paper argues that transition countries could be divided into two relatively homogeneous 
groups based on their EU membership status and Table 1 substantiates this claim. Specifically, 
Table 1 provides means and standard deviations for all covariates for four disjoint sets of countries 
defined by EU membership status and year of survey.  
Some important socio-demographic differences between new EU members and other transition 
countries exist. Households from transition countries in the EU are smaller and more likely to live 
in a city, have fewer children and more adults over the age of 60. These results are expected for 
more developed transition countries in the EU. Lower numbers of respondents with post-
secondary and higher education look surprising at first but can also be explained by the lower 
quality of education and a large number of "diploma mills" in many of the former Soviet Union 
republics. Similarly, socio-economic variables indicate a higher level of development of new EU 
members based on a larger share of households living in apartments, owning a car, having a 
computer and access to the internet. 
                                                          
7 In 2016 non-EU transition countries included Albania, Armenia, Azerbaijan, Belarus, Bosnia and Herzegovina, 
Georgia, Kazakhstan, Kosovo, Kyrgyz Republic, Macedonia FYR, Moldova, Mongolia, Montenegro, Russian 
Federation, Serbia, Tajikistan, Ukraine and Uzbekistan. Bulgaria, Croatia, Czech Republic, Estonia, Hungary, Latvia, 
Lithuania, Poland, Romania, Slovak Republic and Slovenia were EU members in 2016. The list of transition countries 
is a standard one following the literature (see, for example, Guriev and Zhuravskaya 2009). 
Table 1. Descriptive statistics for covariates divided by EU membership status and year 
Variable 
non EU in 
2010 
EU in 2010 
non EU in 
2016 
EU in 2016 
Household size 3.489 2.492 3.302 2.229 
 (1.871) (1.300) (1.827) (1.238) 
Household size squared 15.673 7.902 14.242 6.499 
 (17.298) (8.550) (16.166) (7.985) 
Respondent age 50.646 51.372 45.828 52.817 
 (15.380) (16.261) (16.583) (17.902) 
Respondent age squared 2801.513 2903.466 2375.165 3110.136 
 (1611.473) (1714.054) (1624.299) (1901.446) 
Number of children under 18 0.772 0.425 0.828 0.355 
 (1.072) (0.784) (1.125) (0.761) 
Number of older adults 0.493 0.535 0.494 0.653 
    over 60 (0.717) (0.743) (0.722) (0.773) 
Respondent with post- 0.200 0.143 0.173 0.128 
   secondary education (0.400) (0.350) (0.379) (0.334) 
Respondent with 0.205 0.179 0.258 0.222 
   higher education (0.404) (0.384) (0.437) (0.415) 
Urban household 0.551 0.630 0.541 0.570 
  (0.497) (0.483) (0.498) (0.495) 
Living in a detached house 0.527 0.440 0.660 0.461 
 (0.499) (0.496) (0.474) (0.498) 
Living in an apartment 0.386 0.516 0.249 0.393 
 (0.487) (0.500) (0.432) (0.488) 
Household with a car 0.420 0.571 0.462 0.598 
 (0.494) (0.495) (0.499) (0.490) 
Household with a computer 0.402 0.614 0.601 0.674 
 (0.490) (0.487) (0.490) (0.469) 
Household with internet 0.292 0.556 0.596 0.674 
  (0.455) (0.497) (0.491) (0.469) 
GDP per capita, constant 107.925 233.285 113.262 240.764 
   100 PPP $ (62.979) (43.587) (61.236) (38.801) 
PPP exchange rate devaluation  37.962 -0.135 38.378 -0.192 
   over last 4 years (33.909) (5.805) (32.763) (5.650) 
ILO estimate of unemployment 11.699 6.387 12.311 10.030 
   in % (7.233) (1.506) (7.875) (2.936) 
Urban population, % 54.318 63.422 54.823 63.283 
 (13.214) (7.476) (13.935) (7.905) 
DPT immunization among 93.613 97.014 90.189 94.832 
    12-23 month old children (4.606) (1.877) (17.254) (3.186) 
Health expenditure per 6.663 14.133 7.636 17.170 
    capita, constant 100 PPP $  (3.955) (4.692) (4.135) (4.769) 
Out-of-pocket health 43.325 24.067 45.416 23.658 
    expenditure, % of total (14.082) (8.041) (10.754) (9.655) 
Public health expenditure,  52.815 71.669 50.366 72.071 
   % in total HE (16.399) (7.361) (14.083) (8.571) 
Public HE, % of  9.820 12.087 10.028 12.559 
   government expenditure (3.356) (1.698) (3.099) (1.777) 
Observations 21317 10698 26671 16529 
Sample statistics are based on the largest possible sample of 75,215 observations. Standard deviations are in parenthesis. Macroeconomic 
variables are lagged 2 years due to data not yet being available for 2015 and 2016.  
 
Most importantly, in 2010 new EU members had much better macroeconomic outcomes and a 
much higher share of public health care financing compared to other transition countries. 
Specifically, this advantage includes GDP per capita in constant PPP dollars ($23,328.5 vs 
$10,792.5), ILO unemployment rate (6.4% vs 11.7%), health expenditures per capita ($1,412.3 vs 
$666.3), out-of-pocket health expenditures (24.1% vs 43.3%), public health care expenditure in 
total HE (71.7% vs 52.8%) and public health care expenditure in total government expenditure 
(12.1% vs 9.8%). In a later section this paper will discuss how changes in public health care 
financing between 2010 and 2016 could relate to observed public health care utilisation changes. 
 
Changes in public health care use 
Figure 1 shows changes in public and private health care utilisation by households between 2010 
and 2016. The top left quadrant includes countries (6 new EU members and only one non-EU 
transition country of Armenia) with fewer households using private health care alone and more 
households using public health care in 2016 compared to 2010. The bottom right quadrant, on the 
other hand, includes 5 new EU members (mostly less developed ones) and 15 non-EU transition 
countries with fewer households using public health care and more relying on private health care 
and pharmacies in 2016 compared to 2010. This figure is indicative of some tectonic reductions in 
household reliance on public health care systems in non-EU member countries in the aftermath 
of the global financial crisis. The next section relies on regression analysis to quantify this change 
controlling for changes in potential determinants of health care use between two repeated cross-
sections of data. 
[Figure 1 about here] 
Table 2 presents the results of difference-in-difference estimation for any health care use (columns 
I and II), public (columns III and IV) and private health care use alone (columns V and VI). The 
discussion of results focuses on full models (columns II, IV and VI) because coefficients in basic 
models are quantitatively very similar. This similarity indicates that results are not driven by 
potential endogeneity of some socio-economic characteristics or their multicollinearity. 
According to the estimates from model (II), households from non-EU transition countries were 
6% points less likely to use any health care in 2010 without any change by 2016. However, model 
(IV) shows a tremendous decline of 22.1% points in the share of households using public health 
care in non-EU transition countries in 2016 compared to other region-year combinations. This 
substantial decline was partially offset by an increase in private health care use as indicated by 
model (VI). Specifically, in 2010 households in non-EU countries were 11.0% less likely to have 
positive private health care expenditures only compared to EU members. The difference has 
reversed by 2016 with non-EU transition countries being 7.1% more likely (p-value of 6.0%) to 
use private health care compared to new EU members. This evidence shows a major shift in non-
EU transition countries away from public health care provision towards private health care 
facilities and pharmacies.  
Table 2. Regression results clustered at the country level with robust standard errors  
  HH used  HH used  HH used  HH used  HH used  HH used  
  any HC any HC public HC public HC private HC private HC 
 (I) (II) (III) (IV) (V) (VI) 
Dummy for 2016 -0.008 -0.011 0.004 0.002 -0.000 0.004    
 (0.009) (0.018) (0.042) (0.047) (0.034) (0.035)    
Dummy for non-EU country -0.037** -0.060*** 0.013 0.053 -0.045 -0.110*** 
 (0.014) (0.019) (0.041) (0.044) (0.033) (0.039)    
Dummy for non-EU country -0.009 -0.012 -0.205*** -0.221*** 0.178*** 0.182*** 
   in 2016 (0.012) (0.018) (0.055) (0.061) (0.048) (0.050)    
Household size 0.040*** 0.044*** 0.039*** 0.045*** 0.001 -0.003    
 (0.004) (0.004) (0.007) (0.007) (0.006) (0.007)    
Household size squared -0.003*** -0.004*** -0.003*** -0.004*** -0.000 0.000    
 (0.000) (0.000) (0.001) (0.001) (0.001) (0.001)    
Respondent age 0.001** 0.001** 0.002 0.002** 0.000 -0.000    
 (0.000) (0.000) (0.001) (0.001) (0.001) (0.001)    
Number of children under 18 0.010*** 0.009*** 0.026*** 0.029*** -0.011* -0.015**  
 (0.003) (0.002) (0.007) (0.007) (0.006) (0.005)    
Number of older adults 0.018*** 0.020*** 0.037*** 0.039*** -0.018*** -0.017*** 
    over 60 (0.003) (0.004) (0.005) (0.004) (0.004) (0.003)    
Respondent with post- 0.019** 0.010** 0.039** 0.030** -0.016 -0.021**  
   secondary education (0.008) (0.005) (0.016) (0.011) (0.014) (0.010)    
Respondent with 0.018*** 0.013*** 0.041*** 0.033*** -0.017 -0.019**  
   higher education (0.006) (0.004) (0.013) (0.009) (0.011) (0.008)    
Urban household -0.008 -0.009 0.022** -0.000 -0.028*** -0.010    
 (0.006) (0.007) (0.010) (0.013) (0.009) (0.011)    
Living in an apartment  0.011  0.049***  -0.032*   
  (0.008)  (0.015)  (0.016)    
Household with internet  0.004  0.024***  -0.016*   
  (0.005)  (0.008)  (0.008)    
GDP per capita, constant  0.000  0.001**  -0.001**  
   100 PPP $  (0.000)  (0.001)  (0.000)    
Health expenditure per  -0.003  -0.009  0.003    
    capita, constant 100 PPP $   (0.003)  (0.008)  (0.006)    
Out-of-pocket health  -0.003*  -0.001  -0.005    
    expenditure, % of total  (0.001)  (0.004)  (0.003)    
Public health expenditure,   -0.004***  -0.004  -0.002    
   % in total HE  (0.001)  (0.003)  (0.003)    
Public HE, % of   0.014***  0.023***  -0.007    
   government expenditure  (0.004)  (0.007)  (0.006)    
Constant 0.806*** 0.879*** 0.450*** 0.262 0.309*** 0.731*** 
 (0.024) (0.115) (0.046) (0.314) (0.038) (0.259)    
Observations 65970 63779 75215 72672 65970 63779    
Adjusted R-squared 0.028 0.043 0.054 0.070 0.031 0.045    
* p<0.10, ** p<0.05, *** p<0.01. Standard errors in parentheses. All models also control for respondent age squared. Full models in 
addition control for those who live in a detached house; PPP exchange rate devaluation over 4 years; ILO estimate of unemployment; percent 
of urban population; DPT immunization rate among children of 12-23 months old. The variables are not significant in most or all cases 
and are not shown to save space.  
 
The probability of public or any health care use increases for bigger households, households with 
more children and older adults and a better educated primary respondent. There is some marginal 
evidence of lower probability of positive private health care expenditures only for households with 
more children and older adults as well as a better educated primary respondent. Results are robust 
to inclusion of multiple country-wide macroeconomic variables which are not significant in most 
cases with one notable exception. Each percentage point increase in the share of public HE in 
total government expenditure is associated with a 1.4% points higher probability of using any 
health care and a 2.3% points higher share of households relying on public health care. The 
negative effect of public health expenditure in the total HE is quantitatively small and not robust 
across specifications.  
 
Robustness checks 
A number of additional models have been estimated in robustness checks. Specifically, sets of 
models with (i) only difference-in-difference dummies and (ii) all covariates except for 
macroeconomic variables produce coefficients which are very similar to those reported in Table 
2. An attentive reader has also observed that there are about 10 thousand more observations in a 
model for public health care use (columns III and IV) compared to the other two types of health 
care use. This happens because of many missing observations for household health care 
expenditures which is, by the way, not equivalent to 0 expenditures on health. Since many 
economists are skeptical about imputing missing observations this paper takes a different route 
and re-estimates models in columns (III) and (IV) for the same sample as in columns (I) and (II). 
The results carry over to this extension as well. An attentive reader may also suspect that results 
are driven by transition countries that are located far away from geographical Europe (like 
Mongolia). They are not. After excluding countries in central Asia (Kazakhstan, Kyrgyz Republic, 
Tajikistan, Uzbekistan and Mongolia) key coefficients remain virtually unaffected.8 All these 
extensive robustness checks confirm that diverging trends in health care use in EU and non-EU 
transition countries are fairly robust in four different model specifications and three different 
sample definitions. 9 
 
Discussion and conclusions 
Health care systems in transition countries (that under the “Semashko” system provided universal 
coverage and free health care services at point of use) suffered from two major shocks after the 
collapse of communism. Fiscal shock reduced the ability of governments to spend on health care 
while integration into the world economy increased relative prices, particularly for medicines and 
energy (Kutzin, Jakab and Cashin 2010). As a result, formal and informal out-of-pocket payments 
became a major part of total health expenditure in many transition countries (Rechel and McKee 
2009).  
This paper shows that transition countries do not represent a homogeneous group with more 
developed new members of the European Union being able to preserve public health care systems 
                                                          
8 Except for the non-EU dummy which becomes insignificant in model II, likely due to a smaller sample. 
9 The results of robustness checks are not provided to save space but are available upon request. 
while less reformed non-EU members experiencing a substantial reduction in public health care 
use in the aftermath of the global financial crisis.  
Careful investigation of descriptive statistics reveals an interesting observation: transition countries 
not belonging to the EU suffered from an increased burden of out-of-pocket expenditures in 
health care financing in the aftermath of the global financial crisis between 2010 and 2016. 
Specifically, by 2016 the share of out-of-pocket expenditures increased while the share of public 
health care expenditure decreased in non-EU transition countries, with the opposite trend for new 
EU members. This deterioration of public financing in non-EU transition countries could further 
exacerbate the problem of informal payments and worsen access to care.  
Even in new European Union member states, under-the-counter payments might prevent 
necessary reforms (Gulácsi 2007) and often provide compensation for the relatively low salaries 
of health care professionals. The situation seems to be much worse in most non-EU transition 
countries despite the fact that the constitution guarantees free medical care in several countries of 
the former Soviet Union. In reality, most respondents who obtained care had to make out-of-
pocket payments with median amounts varying from $13 in Belarus to $100 in Azerbaijan 
(Balabanova et al. 2012). What is worse, half of respondents did not seek medical care despite 
health problems and cost is the most cited reason for that (Balabanova et al. 2012). 
Informal payments may also limit access to public health care systems in less reformed non-EU 
transition countries, as indicated by an increased reliance on self-care and traditional healers in the 
Caucasus, central Asia, Republic of Moldova and Ukraine with formal medical care serving only 
as a last resort (Gotsadze, Zoidze and Vasadze 2005, Rechel and McKee 2009).  
If one believes in equity benefits from access to public health care for all compared to private out-
of-pocket expenditures on health care, this paper demonstrates a clear benefit of EU membership 
and associated market reforms. 
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 Figure 1. Changes in the utilisation of public and private health care by transition countries 
between 2010 and 2016.  
Each point represents the difference between the share of households using private (horizontal axis) and public health 
care (vertical axis) in 2016 and 2010. Squares represent transition countries that were not EU members in 2016. 
Triangles represent transition countries that were in the EU in 2016.  
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